معرفی
Xiaoqi Lin, MD, PhD is a Professor in the Department of Pathology at the Feinberg School of Medicine, Northwestern University, specializing in Cytopathology and Surgical Pathology with subspecialty expertise in Thoracic and Renal Pathology. He maintains clinical practice at Northwestern Memorial Hospital.
Education:
- MD from China Medical University (1985)
- PhD from Chinese Academy of Medical Sciences and Peking Union College (1991)
- Residency at Allegheny General Hospital (2006)
- Fellowship at Allegheny General Hospital (2007)
Research Focus: Dr. Lin's work centers on cytomorphological analysis and molecular mechanisms in renal neoplasms, thoracic pathologies, and malignant effusions. His research bridges diagnostic cytopathology with surgical pathology, emphasizing TFE3-rearranged renal cell carcinoma, Birt-Hogg-Dubé syndrome-related tumors, and cytology-biopsy correlations in challenging effusion cases. Recent publications demonstrate increasing emphasis on molecular diagnostics and clinicopathological correlations in renal pathology.
Publication Trends: His 2024-2025 publications reveal concentrated investigation into renal tumor pathogenesis, with growing integration of molecular markers and genetic syndromes. Work consistently connects cytomorphological features with clinical outcomes, particularly in renal and thoracic pathologies.
Honors:
- CAPA Member of the Year Award (2020)
- Papanicolaou Award (2007)
- Mayo Foundation Neurology Research Award (1997)
Professional Leadership: Current roles include Chair of Papanicolaou Society's Budget Committee (2024-present), Treasurer (2023-present), and active service on CAPA Cytopathology Subcommittee. He serves on editorial boards for Cancer - Cytopathology and Journal of American Society of Cytopathology.
Advising & Grants: Profile does not specify current advisees or grant funding details.
Collaborative Structure: Works within Northwestern Memorial Hospital's integrated pathology services, contributing to Cytopathology and Thoracic Pathology divisions through multidisciplinary clinical and research teams.
